Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dilaudid CR in Chronic Low Back Pain
NCT00398788Phase 2Completed
- Sponsor
- ALZA Corporation
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, open-label, single-arm trial of hydromorphone in chronic low back pain (CLBP), sponsored by ALZA Corporation. Primary endpoint: Mean pain relief rating at 4 weeks. Status: completed.
02
Drugs
hydromorphone
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00398788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398788.